Search Results - "Kritzer, Michael"

Refine Results
  1. 1
  2. 2

    Case 34-2022: A 57-Year-Old Woman with Covid-19 and Delusions by Fricchione, Gregory L., Paul, Aaron B., Chemali, Zeina, Kritzer, Michael D.

    Published in The New England journal of medicine (10-11-2022)
    “…A 57-year-old woman with major depressive disorder and Covid-19 was hospitalized for treatment with oxygen, remdesivir, and dexamethasone. Ten days later, she…”
    Get full text
    Journal Article
  3. 3

    Electroconvulsive Therapy: Mechanisms of Action, Clinical Considerations, and Future Directions by Kritzer, Michael D., Peterchev, Angel V., Camprodon, Joan A.

    Published in Harvard review of psychiatry (01-05-2023)
    “…• Outline and discuss the fundamental physiologic, cellular, and molecular mechanisms of ECT to devise strategies to optimize therapeutic outcomes• Summarize…”
    Get full text
    Journal Article
  4. 4

    The Impact of Sex Hormones on Transcranial Magnetic Stimulation Measures of Cortical Excitability: A Systematic Review and Considerations for Clinical Practice by Rivas-Grajales, Ana Maria, Barbour, Tracy, Camprodon, Joan A., Kritzer, Michael D.

    Published in Harvard review of psychiatry (01-05-2023)
    “…Repetitive transcranial magnetic stimulation (rTMS) has emerged as a promising alternative for the treatment of major depressive disorder (MDD), although its…”
    Get full text
    Journal Article
  5. 5

    AKAPs: The architectural underpinnings of local cAMP signaling by Kritzer, Michael D, Li, Jinliang, Dodge-Kafka, Kimberly, Kapiloff, Michael S

    “…Abstract The cAMP-dependent protein kinase A (PKA) is targeted to specific compartments in the cardiac myocyte by A-kinase anchoring proteins (AKAPs), a…”
    Get full text
    Journal Article
  6. 6

    Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress by Kritzer, Michael D, Mischel, Nicholas A, Young, Jonathan R, Lai, Christopher S, Masand, Prakash S, Szabo, Steven T, Mathew, Sanjay J

    Published in Annals of clinical psychiatry (01-11-2021)
    “…Mood disorders are a leading cause of morbidity. Many patients experience treatment-resistant depression (TRD), and suicide rates are rising. Faster-acting and…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Resilience as a translational endpoint in the treatment of PTSD by Rakesh, Gopalkumar, Morey, Rajendra A., Zannas, Anthony S., Malik, Zainab, Marx, Christine E., Clausen, Ashley N., Kritzer, Michael D., Szabo, Steven T.

    Published in Molecular psychiatry (01-09-2019)
    “…Resilience is a neurobiological entity that shapes an individual’s response to trauma. Resilience has been implicated as the principal mediator in the…”
    Get full text
    Journal Article
  9. 9

    Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability by Kritzer, Michael D, Pae, Chi-Un, Masand, Prakash S

    Published in Expert opinion on drug safety (03-06-2022)
    “…Racemic ketamine, a derivative of phencyclidine, has been used as a dissociative anesthetic since 1970. In 2000, the first randomized controlled trial showed a…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Defining a Neurostimulation-Focused Subspecialty: Perspectives Inspired by a Debate at the 2023 Clinical TMS Society Annual Meeting by Trapp, Nicholas T., Barbour, Tracy, Kritzer, Michael D., Pottanat, Roger, Carreon, David, Chen, Leo, Brown, Joshua, Siddiqi, Shan

    Published in Academic psychiatry (01-10-2024)
    “…Neurotechnologies in clinical practice Neurotechnology US FDA-cleared indication (year) Brain stimulation techniques Deep brain stimulation Essential tremor…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Electroconvulsive Therapy Changes Immunological Markers in Patients With Major Depressive Disorder: A Scoping Review by Young, Jonathan R, Evans, Mariah K, Hwang, Julie, Kritzer, Michael D, Kellner, Charles H, Weiner, Richard D

    Published in The journal of ECT (20-06-2024)
    “…Major depressive disorder (MDD) is a highly prevalent and disabling condition. As such, understanding the causes of and treatment options for MDD is critical…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature by Young, Jonathan R., Smani, Shayan A., Mischel, Nicholas A., Kritzer, Michael D., Appelbaum, Lawrence G., Patkar, Ashwin A.

    Published in Journal of addictive diseases (17-02-2020)
    “…The U.S. is currently facing an unprecedented epidemic of opioid-related deaths. Despite the efficacy of the current treatments for opioid use disorder (OUD),…”
    Get full text
    Journal Article
  17. 17

    Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress by Kritzer, Michael D, Mischel, Nicholas A, Young, Jonathan R, Lai, Christopher S, Masand, Prakash S, Szabo, Steven T, Mathew, Sanjay J

    Published in Annals of clinical psychiatry (01-02-2022)
    “…Mood disorders are a leading cause of morbidity. Many patients experience treatment-resistant depression (TRD), and suicide rates are rising. Faster-acting and…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20